期刊
CURRENT OPINION IN MICROBIOLOGY
卷 14, 期 5, 页码 532-543出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2011.07.030
关键词
-
类别
资金
- NIH [GM41376, AI072766, AI90837]
- Global Alliance for TB Drug Development contract
- Howard Hughes Medical Institute
A new drug target - the 'switch region' - has been identified within bacterial RNA polymerase (RNAP), the enzyme that mediates bacterial RNA synthesis. The new target serves as the binding site for compounds that inhibit bacterial RNA synthesis and kill bacteria. Since the new target is present in most bacterial species, compounds that bind to the new target are active against a broad spectrum of bacterial species. Since the new target is different from targets of other antibacterial agents, compounds that bind to the new target are not cross-resistant with other antibacterial agents. Four antibiotics that function through the new target have been identified: myxopyronin, corallopyronin, ripostatin, and lipiarmycin. This review summarizes the switch region, switch-region inhibitors, and implications for antibacterial drug discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据